Taylor Morrison Home Statistics
Total Valuation
TMHC has a market cap or net worth of $6.71 billion. The enterprise value is $8.75 billion.
| Market Cap | 6.71B |
| Enterprise Value | 8.75B |
Important Dates
The next estimated earnings date is Wednesday, October 22, 2025, before market open.
| Earnings Date | Oct 22, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TMHC has 98.84 million shares outstanding. The number of shares has decreased by -4.61% in one year.
| Current Share Class | 98.84M |
| Shares Outstanding | 98.84M |
| Shares Change (YoY) | -4.61% |
| Shares Change (QoQ) | -2.03% |
| Owned by Insiders (%) | 0.60% |
| Owned by Institutions (%) | 99.77% |
| Float | 98.21M |
Valuation Ratios
The trailing PE ratio is 7.83 and the forward PE ratio is 9.62.
| PE Ratio | 7.83 |
| Forward PE | 9.62 |
| PS Ratio | 0.83 |
| Forward PS | 0.87 |
| PB Ratio | 1.12 |
| P/TBV Ratio | 1.25 |
| P/FCF Ratio | 13.68 |
| P/OCF Ratio | 12.76 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.47, with an EV/FCF ratio of 17.84.
| EV / Earnings | 9.72 |
| EV / Sales | 1.04 |
| EV / EBITDA | 6.47 |
| EV / EBIT | 6.67 |
| EV / FCF | 17.84 |
Financial Position
The company has a current ratio of 7.61, with a Debt / Equity ratio of 0.36.
| Current Ratio | 7.61 |
| Quick Ratio | 0.36 |
| Debt / Equity | 0.36 |
| Debt / EBITDA | 1.59 |
| Debt / FCF | 4.43 |
| Interest Coverage | 41.56 |
Financial Efficiency
Return on equity (ROE) is 15.63% and return on invested capital (ROIC) is 10.26%.
| Return on Equity (ROE) | 15.63% |
| Return on Assets (ROA) | 8.85% |
| Return on Invested Capital (ROIC) | 10.26% |
| Return on Capital Employed (ROCE) | 15.60% |
| Revenue Per Employee | $2.80M |
| Profits Per Employee | $300,207 |
| Employee Count | 3,000 |
| Asset Turnover | 0.91 |
| Inventory Turnover | 0.97 |
Taxes
In the past 12 months, TMHC has paid $276.64 million in taxes.
| Income Tax | 276.64M |
| Effective Tax Rate | 23.41% |
Stock Price Statistics
The stock price has decreased by -1.19% in the last 52 weeks. The beta is 1.59, so TMHC's price volatility has been higher than the market average.
| Beta (5Y) | 1.59 |
| 52-Week Price Change | -1.19% |
| 50-Day Moving Average | 65.79 |
| 200-Day Moving Average | 62.35 |
| Relative Strength Index (RSI) | 49.73 |
| Average Volume (20 Days) | 1,114,643 |
Short Selling Information
The latest short interest is 3.11 million, so 3.15% of the outstanding shares have been sold short.
| Short Interest | 3.11M |
| Short Previous Month | 3.43M |
| Short % of Shares Out | 3.15% |
| Short % of Float | 3.17% |
| Short Ratio (days to cover) | 2.67 |
Income Statement
In the last 12 months, TMHC had revenue of $8.40 billion and earned $900.62 million in profits. Earnings per share was $8.67.
| Revenue | 8.40B |
| Gross Profit | 2.08B |
| Operating Income | 1.31B |
| Pretax Income | 968.08M |
| Net Income | 900.62M |
| EBITDA | 1.35B |
| EBIT | 1.31B |
| Earnings Per Share (EPS) | $8.67 |
Balance Sheet
The company has $130.17 million in cash and $2.17 billion in debt, giving a net cash position of -$2.04 billion or -$20.68 per share.
| Cash & Cash Equivalents | 130.17M |
| Total Debt | 2.17B |
| Net Cash | -2.04B |
| Net Cash Per Share | -$20.68 |
| Equity (Book Value) | 6.06B |
| Book Value Per Share | 61.19 |
| Working Capital | 6.86B |
Cash Flow
In the last 12 months, operating cash flow was $525.41 million and capital expenditures -$35.08 million, giving a free cash flow of $490.33 million.
| Operating Cash Flow | 525.41M |
| Capital Expenditures | -35.08M |
| Free Cash Flow | 490.33M |
| FCF Per Share | $4.96 |
Margins
Gross margin is 24.70%, with operating and profit margins of 15.62% and 10.72%.
| Gross Margin | 24.70% |
| Operating Margin | 15.62% |
| Pretax Margin | 14.06% |
| Profit Margin | 10.72% |
| EBITDA Margin | 16.08% |
| EBIT Margin | 15.62% |
| FCF Margin | 5.83% |
Dividends & Yields
TMHC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 4.61% |
| Shareholder Yield | 4.61% |
| Earnings Yield | 13.43% |
| FCF Yield | 7.31% |
Analyst Forecast
The average price target for TMHC is $79.38, which is 16.87% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $79.38 |
| Price Target Difference | 16.87% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TMHC has an Altman Z-Score of 4.08 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.08 |
| Piotroski F-Score | 6 |